117 related articles for article (PubMed ID: 19922146)
1. CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.
Van Rooij FG; Schelhaas HJ; Lammers GJ; Verbeek MM; Overeem S
Amyotroph Lateral Scler; 2009; 10(5-6):487-9. PubMed ID: 19922146
[TBL] [Abstract][Full Text] [Related]
2. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
[TBL] [Abstract][Full Text] [Related]
4. Hypocretin (orexin) loss in Parkinson's disease.
Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
[TBL] [Abstract][Full Text] [Related]
5. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
[TBL] [Abstract][Full Text] [Related]
6. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
Knudsen S; Gammeltoft S; Jennum PJ
Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
[TBL] [Abstract][Full Text] [Related]
7. CSF hypocretin-1 levels are normal in multiple-system atrophy.
Abdo WF; Bloem BR; Kremer HP; Lammers GJ; Verbeek MM; Overeem S
Parkinsonism Relat Disord; 2008; 14(4):342-4. PubMed ID: 17977056
[TBL] [Abstract][Full Text] [Related]
8. Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.
Baumann CR; Stocker R; Imhof HG; Trentz O; Hersberger M; Mignot E; Bassetti CL
Neurology; 2005 Jul; 65(1):147-9. PubMed ID: 16009905
[TBL] [Abstract][Full Text] [Related]
9. Hypocretin/orexin disturbances in neurological disorders.
Fronczek R; Baumann CR; Lammers GJ; Bassetti CL; Overeem S
Sleep Med Rev; 2009 Feb; 13(1):9-22. PubMed ID: 18819824
[TBL] [Abstract][Full Text] [Related]
10. Hypocretin (orexin) loss in Alzheimer's disease.
Fronczek R; van Geest S; Frölich M; Overeem S; Roelandse FW; Lammers GJ; Swaab DF
Neurobiol Aging; 2012 Aug; 33(8):1642-50. PubMed ID: 21546124
[TBL] [Abstract][Full Text] [Related]
11. Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study.
Baumann CR; Werth E; Stocker R; Ludwig S; Bassetti CL
Brain; 2007 Jul; 130(Pt 7):1873-83. PubMed ID: 17584779
[TBL] [Abstract][Full Text] [Related]
12. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
Baumann CR; Bassetti CL
Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
14. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
Knudsen S; Jennum PJ; Korsholm K; Sheikh SP; Gammeltoft S; Frederiksen JL
Mult Scler; 2008 Jul; 14(6):734-8. PubMed ID: 18505777
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache.
Cevoli S; Pizza F; Grimaldi D; Nicodemo M; Favoni V; Pierangeli G; Valko PO; Baumann CR; Montagna P; Bassetti CL; Cortelli P
Cephalalgia; 2011 Jun; 31(8):973-6. PubMed ID: 21444644
[TBL] [Abstract][Full Text] [Related]
16. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
[TBL] [Abstract][Full Text] [Related]
17. Narcolepsy in Parkinson's disease.
Haq IZ; Naidu Y; Reddy P; Chaudhuri KR
Expert Rev Neurother; 2010 Jun; 10(6):879-84. PubMed ID: 20518604
[TBL] [Abstract][Full Text] [Related]
18. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.
Baumann CR; Dauvilliers Y; Mignot E; Bassetti CL
Eur Neurol; 2004; 52(2):73-6. PubMed ID: 15256827
[TBL] [Abstract][Full Text] [Related]
19. Hypocretin/orexin, sleep and narcolepsy.
Hungs M; Mignot E
Bioessays; 2001 May; 23(5):397-408. PubMed ID: 11340621
[TBL] [Abstract][Full Text] [Related]
20. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH).
Dohi K; Ripley B; Fujiki N; Ohtaki H; Shioda S; Aruga T; Nishino S
Peptides; 2005 Nov; 26(11):2339-43. PubMed ID: 15893406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
